5MJC BCU 23: Outcomes of Women Who Were Premenopausal at Diagnosis in the MA17 Trial of Extended Letrozole After Five Years of Tamoxifen
Outcomes of Women Who Were Premenopausal at Diagnosis in the MA17 Trial of Extended Letrozole After Five Years of Tamoxifen Slides from a presentation at SABCS 2009 and transcribed comments from a recent interview with Rowan T Chlebowski, MD, PhD (12/30/09)Dr Chlebowski is Professor of Medicine at the David Geffen School of Medicine at UCLA and Chief of the Division of Medical Oncology and Hematology at Harbor-UCLA Medical Center in Torrance, California. Presentation discussed in this issue: Goss PE et al. Outcomes of women who were premenopausal at diagnosis of early stage breast cancer in the NCIC CTG MA17 trial. San Antonio Breast Cancer Symposium 2009;Abstract 13. Go to previous Journal Club Go to next Journal Club
|